hg-9-91-01 and Hyperglycemia

hg-9-91-01 has been researched along with Hyperglycemia* in 1 studies

Other Studies

1 other study(ies) available for hg-9-91-01 and Hyperglycemia

ArticleYear
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.
    Nature communications, 2014, Aug-04, Volume: 5

    LKB1 is a master kinase that regulates metabolism and growth through adenosine monophosphate-activated protein kinase (AMPK) and 12 other closely related kinases. Liver-specific ablation of LKB1 causes increased glucose production in hepatocytes in vitro and hyperglycaemia in fasting mice in vivo. Here we report that the salt-inducible kinases (SIK1, 2 and 3), members of the AMPK-related kinase family, play a key role as gluconeogenic suppressors downstream of LKB1 in the liver. The selective SIK inhibitor HG-9-91-01 promotes dephosphorylation of transcriptional co-activators CRTC2/3 resulting in enhanced gluconeogenic gene expression and glucose production in hepatocytes, an effect that is abolished when an HG-9-91-01-insensitive mutant SIK is introduced or LKB1 is ablated. Although SIK2 was proposed as a key regulator of insulin-mediated suppression of gluconeogenesis, we provide genetic evidence that liver-specific ablation of SIK2 alone has no effect on gluconeogenesis and insulin does not modulate SIK2 phosphorylation or activity. Collectively, we demonstrate that the LKB1-SIK pathway functions as a key gluconeogenic gatekeeper in the liver.

    Topics: AMP-Activated Protein Kinases; Animals; Fasting; Gene Expression Regulation; Glucagon; Gluconeogenesis; Glucose; Hepatocytes; Hyperglycemia; Insulin; Liver; Male; Mice; Mice, Knockout; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Signal Transduction; Transcription Factors

2014